aInstitute of Immunology, University of Bern, Switzerland;
Swiss Med Wkly. 2014 Feb 4;144:w13914. doi: 10.4414/smw.2014.13914.
Modern medicine wields the power to treat large numbers of diseases and injuries most of us would have died from just a hundred years ago, yet many of the most devastating diseases of our time are still untreatable. Chronic conditions of age such as cardiovascular disease, diabetes, osteoarthritis or Alzheimer's disease turn out to be of a complexity that may require transformative ideas and paradigms to understand and treat them. Parabiosis, which is characterised by a shared blood supply between two surgically connected animals, may just provide such a transformative experimental paradigm. Although forgotten and shunned now in many countries, it has contributed to major breakthroughs in tumour biology, endocrinology and transplantation research in the past century. Interestingly, recent studies from the United States and Britain are reporting stunning advances in stem cell biology and tissue regeneration using parabiosis between young and old mice, indicating a possible revival of this paradigm. We review here briefly the history of parabiosis and discuss its utility to study physiological and pathophysiological processes. We argue that parabiosis is a technique that should enjoy wider acceptance and application, and that policies should be revisited to allow its use in biomedical research.
现代医学拥有治疗许多疾病和伤害的能力,而在仅仅一百年前,我们中的大多数人都会因此而死亡,但我们这个时代许多最具破坏性的疾病仍然无法治愈。随着年龄的增长而出现的慢性疾病,如心血管疾病、糖尿病、骨关节炎或老年痴呆症,其复杂性可能需要变革性的理念和范式来理解和治疗。联体共生,即通过手术连接的两个动物之间共享血液供应,可能正是提供了这样一种变革性的实验范式。尽管在许多国家现在已经被遗忘和回避,但它在上个世纪的肿瘤生物学、内分泌学和移植研究方面做出了重大突破。有趣的是,最近来自美国和英国的研究报告称,在年轻和年老老鼠之间使用联体共生进行干细胞生物学和组织再生方面取得了惊人的进展,这表明这种范式可能会复兴。我们在这里简要回顾联体共生的历史,并讨论其在研究生理和病理生理过程中的应用。我们认为,联体共生是一种应该得到更广泛接受和应用的技术,应该重新审视政策以允许其在生物医学研究中使用。